Early backer of breakthrough,
founder-led longevity companies
First-in-class foundational checkpoint immunotherapies
NASDAQ: ALXO
Discovering new medicines with ultra-throughput biochemistry and machine learning
Next-generation interventions to cure neurodegeneration and delay brain aging
Targeting pathogenic cells to treat aging and chronic diseases
Turning stem cells into human eggs to reimagine family planning
Regenerative and gene therapies to restore hearing and balance
NASDAQ: DBTX
Activation of the endogenous immune system for eliminating pathogenic cells
AI-led drug discovery engine translating conserved pathways of disease resistance across species
Next generation of induced proximity medicines
Pooled in vivo platform for new therapeutics tackling complex age-related disease
Healthspan and lifespan extension for dogs
Therapies for gastrointestinal and liver disease
NASDAQ: MTCR
Platform for therapeutics targeting mTORC1
Novel gene editing technology to develop new class of medicines
NASDAQ: DTIL
Therapeutics to heal the blood-brain barrier
Redefining human capabilities with advanced medical technology
Machine learning platform to accelerate drug discovery for aging
Therapeutics to slow, halt, or reverse diseases of aging
NASDAQ: UBX
Stealth
Cryopreservation technology for tissues and organs to end organ supply shortages
Stealth
Developing therapies targeting gut-organ-axes to increase healthspan
Stealth
Multiplex-editing therapies to target age-related disease